210 related articles for article (PubMed ID: 30826934)
1. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
Lee J; Lim B; Pearson T; Choi K; Fuson JA; Bartholomeusz C; Paradiso LJ; Myers T; Tripathy D; Ueno NT
Breast Cancer Res Treat; 2019 Jun; 175(2):339-351. PubMed ID: 30826934
[TBL] [Abstract][Full Text] [Related]
2. Arnicolide D Inhibits Triple Negative Breast Cancer Cell Proliferation by Suppression of Akt/mTOR and STAT3 Signaling Pathways.
Qu Z; Lin Y; Mok DK; Bian Q; Tai WC; Chen S
Int J Med Sci; 2020; 17(11):1482-1490. PubMed ID: 32669950
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer.
Li H; Liu L; Chang H; Zou Z; Xing D
Cell Death Dis; 2018 Jan; 9(2):137. PubMed ID: 29374168
[TBL] [Abstract][Full Text] [Related]
4. C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple-negative breast cancer.
Liao L; Deng L; Zhang YL; Yang SY; Andriani L; Hu SY; Zhang FL; Shao ZM; Li DQ
Clin Transl Med; 2023 Nov; 13(11):e1480. PubMed ID: 38009308
[TBL] [Abstract][Full Text] [Related]
5. The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis.
Feng Z; Xia Y; Gao T; Xu F; Lei Q; Peng C; Yang Y; Xue Q; Hu X; Wang Q; Wang R; Ran Z; Zeng Z; Yang N; Xie Z; Yu L
Cell Death Dis; 2018 Sep; 9(10):1006. PubMed ID: 30258182
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of CDK9 in triple negative breast cancer.
Mustafa EH; Laven-Law G; Kikhtyak Z; Nguyen V; Ali S; Pace AA; Iggo R; Kebede A; Noll B; Wang S; Winter JM; Dwyer AR; Tilley WD; Hickey TE
Oncogene; 2024 Jan; 43(3):202-215. PubMed ID: 38001268
[TBL] [Abstract][Full Text] [Related]
7. Novel combinatorial autophagy inhibition therapy for triple negative breast cancers.
Abd El-Aziz YS; Toit-Thompson TD; McKay MJ; Molloy MP; Stoner S; McDowell B; Moon E; Sioson L; Sheen A; Chou A; Gill AJ; Jansson PJ; Sahni S
Eur J Pharmacol; 2024 Jun; 973():176568. PubMed ID: 38604544
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin prevents lung metastasis in triple-negative breast cancer by triggering autophagy via the RhoB/PI3K/mTOR pathway.
Xu WH; Zhang T; Zhou Y; Mao Y
Exp Cell Res; 2024 Feb; 435(1):113893. PubMed ID: 38123008
[TBL] [Abstract][Full Text] [Related]
9. The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
Qian J; Ma Y; Tahaney WM; Moyer CL; Lanier A; Hill J; Coleman D; Koupaei N; Hilsenbeck SG; Savage MI; Page BDG; Mazumdar A; Brown PH
Breast Cancer Res; 2024 Feb; 26(1):23. PubMed ID: 38317231
[TBL] [Abstract][Full Text] [Related]
10. Blocking LBH expression causes replication stress and sensitizes triple-negative breast cancer cells to ATR inhibitor treatment.
Garikapati K; Young IC; Hong S; Rai P; Jain C; Briegel KJ
Oncogene; 2024 Mar; 43(12):851-865. PubMed ID: 38297083
[TBL] [Abstract][Full Text] [Related]
11. Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family.
Kawai M; Nakashima A; Kamada S; Kikkawa U
J Biomed Sci; 2015 Jul; 22(1):48. PubMed ID: 26141684
[TBL] [Abstract][Full Text] [Related]
12. Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer.
Liu Z; He K; Ma Q; Yu Q; Liu C; Ndege I; Wang X; Yu Z
PLoS One; 2017; 12(5):e0177694. PubMed ID: 28531218
[TBL] [Abstract][Full Text] [Related]
13. Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer.
Ge JY; Shu S; Kwon M; Jovanović B; Murphy K; Gulvady A; Fassl A; Trinh A; Kuang Y; Heavey GA; Luoma A; Paweletz C; Thorner AR; Wucherpfennig KW; Qi J; Brown M; Sicinski P; McDonald TO; Pellman D; Michor F; Polyak K
Nat Commun; 2020 May; 11(1):2350. PubMed ID: 32393766
[TBL] [Abstract][Full Text] [Related]
14. The ATR inhibition by Elimusertib enhances the radiosensitivity of MDA-MB-231 triple negative breast cancer in vitro.
Guney Eskiler G; Halis H; Hamarat KF; Derlioglu RR; Ugurlu BT; Haciefendi A
Int J Radiat Biol; 2024; 100(5):715-723. PubMed ID: 38421209
[TBL] [Abstract][Full Text] [Related]
15. Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis.
Guo P; Yang J; Liu D; Huang L; Fell G; Huang J; Moses MA; Auguste DT
Sci Adv; 2019 Mar; 5(3):eaav5010. PubMed ID: 30906868
[TBL] [Abstract][Full Text] [Related]
16. Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells.
Calahorra J; Blaya-Cánovas JL; Castellini-Pérez O; Aparicio-Puerta E; Cives-Losada C; Marin JJG; Rementeria M; Cara FE; López-Tejada A; Griñán-Lisón C; Aulicino F; Berger I; Marchal JA; Delgado-Almenta V; Granados-Principal S
Biomed Pharmacother; 2024 May; 174():116439. PubMed ID: 38518601
[TBL] [Abstract][Full Text] [Related]
17. PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression.
Peng ZM; Han XJ; Wang T; Li JJ; Yang CX; Tou FF; Zhang Z
Breast Cancer Res; 2024 Jan; 26(1):10. PubMed ID: 38217030
[TBL] [Abstract][Full Text] [Related]
18. LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m
Yu Y; Deng H; Wang W; Xiao S; Zheng R; Lv L; Wang H; Chen J; Zhang B
Clin Transl Med; 2024 Feb; 14(2):e1583. PubMed ID: 38372449
[TBL] [Abstract][Full Text] [Related]
19. Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of Src and p38 MAPK to promote TNBC progression.
Deng Y; Hou Z; Li Y; Yi M; Wu Y; Zheng Y; Yang F; Zhong G; Hao Q; Zhai Z; Wang M; Ma X; Kang H; Ji F; Dong C; Liu H; Dai Z
Cell Commun Signal; 2024 Feb; 22(1):115. PubMed ID: 38347536
[TBL] [Abstract][Full Text] [Related]
20. Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs.
Nimal S; Kumbhar N; Saruchi ; Rathore S; Naik N; Paymal S; Gacche RN
Sci Rep; 2024 Apr; 14(1):9540. PubMed ID: 38664447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
